Lito Kyritsi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite major advances in the molecular biology of the cancer cell over the past two decades, the great majority of patients are still treated by conventional cytotoxic drugs. The chemotherapy regimens employed frequently include platinating agents, taxanes, intercalating agents and topoisomerase inhibitors. Attempts to predict the therapeutic efficacy of(More)
  • 1